Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00912977

Enrollment

Registered

2009-06-03

Start date

2009-06-30

Completion date

2010-06-30

Last updated

2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinsons disease, dyskinesia, measurement

Brief summary

Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.

Detailed description

The main outcome measure of this study are measurements taken every half hour during an inpatient study visit. These measurements include standing on a forceplate for 1 minute while performing a mental task such as reciting the alphabet backwards. During this forceplate stance, a rater will visually score your movements. All participants must be eligible for another Parkinson's disease study at Oregon Health and Science University.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Parkinsons disease * Older than 18

Exclusion criteria

* Must be participating in a Parkinsons disease study at Oregon Health & Science University

Design outcomes

Primary

Measure	Time frame
Forceplate Measure	Every 1/2 hour

Secondary

Measure	Time frame
Visual Rating Scale	every 1/2 hour

Countries

United States

Outcome results